The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.

Saved in:
Bibliographic Details
Title: The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.
Authors: Mazumdar A; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Medina D, Kittrell FS, Zhang Y, Hill JL, Edwards DE, Bissonnette RP, Brown PH
Source: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2012 Oct; Vol. 5 (10), pp. 1195-202. Date of Electronic Publication: 2012 Aug 27.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1940-6215
DOI:10.1158/1940-6207.CAPR-11-0524